Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  270 results for ""GLUCAGON-like peptide-1 receptor""

Your Filters

Publisher : american physiological society
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Vascular regeneration: a new mechanism of glucagon-like peptide-1 receptor agonist-mediated cardioprotection?

  • Authors : Chan JSF; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada.

Subjects: Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists ; Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/metabolism ; Regeneration*/Regeneration*/Regeneration*/drug effects

  • Source: American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2024 Aug 01; Vol. 327 (2), pp. H406-H408. Date of Electronic Publication: 2024 Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901228 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes.

  • Authors : Park B; Division of Cardiac Surgery, St. Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.; Keenan Research Centre for Biomedical Science, St Michael's Hospital, Toronto, Ontario, Canada.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: American journal of physiology. Heart and circulatory physiology [Am J Physiol Heart Circ Physiol] 2024 Aug 01; Vol. 327 (2), pp. H370-H376. Date of Electronic Publication: 2024 Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901228 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Reduced incretin receptor trafficking upon activation enhances glycemic control and reverses obesity in diet-induced obese mice.

  • Authors : Bauri R; Dr. Reddy's Institute of Life Sciences, University of Hyderabad Campus, Hyderabad, India.; Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.

Subjects: Obesity*/Obesity*/Obesity*/metabolism ; Obesity*/Obesity*/Obesity*/drug therapy ; Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/agonists

  • Source: American journal of physiology. Cell physiology [Am J Physiol Cell Physiol] 2024 Jul 01; Vol. 327 (1), pp. C74-C96. Date of Electronic Publication: 2024 May 13.Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901225 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Intestinal perfusion of unacylated ghrelin alleviated metabolically associated fatty liver disease in rats via a central glucagon-like peptide-1 pathway.

  • Authors : Lv P; Department of Pharmacy, College of Chemical Engineering, Qingdao University of Science and Technology, Qingdao, People's Republic of China.; Li H

Subjects: Ghrelin*/Ghrelin*/Ghrelin*/metabolism ; Ghrelin*/Ghrelin*/Ghrelin*/pharmacology ; Glucagon-Like Peptide 1*/Glucagon-Like Peptide 1*/Glucagon-Like Peptide 1*/metabolism

  • Source: American journal of physiology. Gastrointestinal and liver physiology [Am J Physiol Gastrointest Liver Physiol] 2024 Jun 01; Vol. 326 (6), pp. G643-G658. Date of Electronic Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901227 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of glucagon-like peptide-1 receptor expression in nondiabetic and diabetic atherosclerotic mice using PET tracer 68 Ga-NODAGA-exendin-4.

Subjects: Atherosclerosis/Atherosclerosis/Atherosclerosis/*metabolism ; Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/Diabetes Mellitus, Experimental/*metabolism ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*metabolism

  • Source: American journal of physiology. Endocrinology and metabolism [Am J Physiol Endocrinol Metab] 2021 May 01; Vol. 320 (5), pp. E989-E998. Date of Electronic Publication: 2021 Apr 12.Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901226 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

In vitro cell cultures of Brunner's glands from male mouse to study GLP-1 receptor function.

  • Authors : Voetmann LM; Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark.; Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.

Subjects: Brunner Glands*/Brunner Glands*/Brunner Glands*/chemistry ; Brunner Glands*/Brunner Glands*/Brunner Glands*/metabolism ; Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/analysis

  • Source: American journal of physiology. Cell physiology [Am J Physiol Cell Physiol] 2022 Jun 01; Vol. 322 (6), pp. C1260-C1269. Date of Electronic Publication: 2022 Apr 20.Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901225 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.

  • Authors : Brown JD; Integrative Metabolism Program, Sanford Burnham Prebys Medical Discovery Institute at Lake Nona , Orlando, Florida.; McAnally D

Subjects: Anti-Obesity Agents/Anti-Obesity Agents/Anti-Obesity Agents/*pharmacology ; Endocannabinoids/Endocannabinoids/Endocannabinoids/*pharmacology ; Exenatide/Exenatide/Exenatide/*pharmacology

  • Source: American journal of physiology. Regulatory, integrative and comparative physiology [Am J Physiol Regul Integr Comp Physiol] 2018 Oct 01; Vol. 315 (4), pp. R595-R608. Date of ElectronicPublisher: American Physiological Society Country of Publication: United States NLM ID: 100901230 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Glucagon-like peptide-1 receptor mediates the beneficial effect of liraglutide in an acute lung injury mouse model involving the thioredoxin-interacting protein.

  • Authors : Zhou W; Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.; Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China.

Subjects: Acute Lung Injury/Acute Lung Injury/Acute Lung Injury/*prevention & control ; Carrier Proteins/Carrier Proteins/Carrier Proteins/*metabolism ; Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/Glucagon-Like Peptide-1 Receptor/*metabolism

  • Source: American journal of physiology. Endocrinology and metabolism [Am J Physiol Endocrinol Metab] 2020 Sep 01; Vol. 319 (3), pp. E568-E578. Date of Electronic Publication: 2020 Jul 29.Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901226 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with β -cell dysfunction.

  • Authors : Esser N; Veterans Affairs Puget Sound Health Care System, Seattle, Washington.; Division of Metabolism, Endocrinology & Nutrition, Department of Medicine, University of Washington, Seattle, Washington.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/Glucagon-Like Peptide-1 Receptor*/metabolism ; Insulin Secretion*

  • Source: American journal of physiology. Endocrinology and metabolism [Am J Physiol Endocrinol Metab] 2022 Mar 01; Vol. 322 (3), pp. E307-E318. Date of Electronic Publication: 2022 Feb 07.Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901226 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Mechanisms underlying the prokinetic effects of endogenous glucagon-like peptide-1 in the rat proximal colon.

  • Authors : Nakamori H; Department of Cell Physiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.; Iida K

Subjects: Gastrointestinal Motility*/Gastrointestinal Motility*/Gastrointestinal Motility*/drug effects; Colon/Colon/Colon/*metabolism ; Enteroendocrine Cells/Enteroendocrine Cells/Enteroendocrine Cells/*metabolism

  • Source: American journal of physiology. Gastrointestinal and liver physiology [Am J Physiol Gastrointest Liver Physiol] 2021 Dec 01; Vol. 321 (6), pp. G617-G627. Date of Electronic Publisher: American Physiological Society Country of Publication: United States NLM ID: 100901227 Publication Model:

Record details

Read More Add to Saved list
×
  • 1-10 of  270 results for ""GLUCAGON-like peptide-1 receptor""